Announcements

JCM is recruiting Editorial Board Members for the following sections:

https://www.mdpi.com/journal/jcm/sections.

The main responsibilities of Editorial Board Members are as follows:

1) Making decisions on whether a manuscript can be accepted based on the reports we collect;

2) Reviewing a small number of papers each year;

3) Acting as or recommending a Guest Editor for a Special Issue on a topic related to your research interests;

4) Promoting JCM and increasing its visibility at related academic conferences.

Journal of Clinical Medicine (ISSN 2077-0383) is an international scientific open-access journal, providing a platform for advances in health care/clinical practices, the study of direct observation of patients, and general medical research. This multi-disciplinary journal is aimed at a wide audience of medical researchers and healthcare professionals. It is abstracted and indexed in the Science Citation Index Expanded in Web of Science and other databases, with citations available in PubMed, and is full-text archived in PubMed Central. The 2019 IF for JCM was 3.303.

This position is open to experts in clinical medicine. To apply for this position (in one of our Sections), recommend potential candidates, or request further information, please contact the JCM Editorial Office (jcm@mdpi.com) or Lily Pei (lily.pei@mdpi.com).

Preterm birth (PTB) remains one of the biggest challenges in contemporary obstetrics as it is associated with an increased risk of mortality as well as short- and long-term morbidity of the offspring. Many risk factors for PTB have been identified, including multiple gestation, placental insufficiency, cervical pathology and uterine factors, among others. As a result, many women are currently classified as at high risk for PTB. Accurate prediction of PTB is crucial as it can assist in selecting the optimal prevention measurements and counseling regarding the suitable antepartum follow up and the need for potential transfer to the appropriate facility in case of very high risk of PTB.

With a distinguished panel of leaders in this field, Professors Liran Hiersch, John Kingdom, Nathan Fox, Tal Biron-Shental and Ido Solt, this webinar will address aspects and perspectives on the prediction of PTB in various clinical scenarios.

Date: 6th December 2020 | 3:00 p.m. CET | 9:00 a.m. EST

Webinar ID: 862 1088 3441

Register for Free Here: https://clincialmed-4.sciforum.net/

Chair:

Speakers:

For any questions about the webinar, please contact us at jcm.webinar@mdpi.com.

MDPI acquired Current Oncology (ISSN 1718-7729) in October 2020 from Multimed Publications Inc., who launched the title in 1994, as Canada’s first peer-reviewed journal in oncology.

Current Oncology features papers in all fields of cancer medicine, including radiation oncology, surgical oncology, medical oncology, pediatric oncology, pathology, and cancer rehabilitation and survivorship. It continues to be a trusted source for all members of the oncology community in Canada and abroad.

Coverage in indexing services includes MEDLINE (PubMed/National Library of Medicine), the Science Citation Index Expanded (Web of Science), Journal Citation Reports, Scopus (Elsevier), EMBASE (Elsevier), and more. Current Oncology's 2019 Impact Factor is 2.257, ranked 185/244 in the 'Oncology' category.

Previously published six times annually, normally with one or two additional supplements, MDPI will continue the schedule of bimonthly publications. The current volume of Current Oncology (v. 27) will be concluded at the end of 2020, at which point MDPI will take over publication of the journal, starting with Volume 28, at the beginning of 2021.

The goal is to greatly expand the journal's global reach, alongside MDPI's flagship Cancers journal, in order to become one of the world’s leading oncology journals.

Website: https://www.mdpi.com/journal/curroncol

Contact: Danica Jevtic, Marko Ristic
Current Oncology Editorial Office

The JCM Outstanding Research Award was initiated to recognize outstanding research by authors of the journal that has had a significant international impact. The novelty and significance of research works were assessed by the JCM Editorial Board and reviewers along with consideration of the citations.

We are very pleased to announce that Dr. Robin Nicholas Thompson will be granted the JCM 2020 Outstanding Research Award for his contribution of using mathematical models to represent the epidemiological or evolutionary behavior of infectious disease outbreaks. The main aims are not only to generate forecasts of specific outbreaks but also to understand how diseases spread such that forecasts can be made, and control interventions can be planned with more precision.

His paper “Novel Coronavirus Outbreak in Wuhan, China, 2020: Intense Surveillance Is Vital for Preventing Sustained Transmission in New Locations” published in February 2020 (https://www.mdpi.com/2077-0383/9/2/498) was recognized as recommended reading by the World Health Organization.

Please join us in congratulating Dr. Thompson on receiving this award.

Dry Eye Disease (DED) has gained recognition as a public health problem given its prevalence, morbidity, and cost implications. DED can have a variety of symptoms including blurred vision and ocular pain (dryness, burning aching) and a variety of signs including decreased tear production, corneal epithelial disruption, and rapid tear evaporation. However, it is well known that there is often a discrepancy between symptoms and signs of disease.

Date: 1.30pm (CET) | 06.30am (CDT)

Duration: Maximum 2 hours

Webinar ID: 961 1378 0758

Register for Free Here: https://sciforum.net/conference/JCM3

Chair:

	Presentation: DED from the outside- a discussion on the interaction between environmental exposures and the ocular surface, and their manifestation as DED.
Associate Professor Anat Galor Guest Editor of “Dry Eye Syndrome: New Insights on Epidemiology and Management”

Speakers:

	Presentation: DED from the inside- a discussion on systemic co-morbidities that may associated and drive disease.
Professor Stephen C. Pflugfelder
	Presentation: DED and the local neighborhood- a discussion on effects of the periocular skin and eyelids on the ocular surface and DED.
Associate Professor Jennifer Craig

For any questions about the webinar, please email jcm.webinar@mdpi.com.

Preterm delivery (PTD; <37 weeks' gestation) complicates 5-13% of deliveries worldwide depending on the geographical and demographical characteristics of the population tested. Based on data from 184 countries, the global average preterm birth rate in 2010 was 11.1% giving a worldwide 14.9 million. It is the leading cause of perinatal morbidity and mortality as well as maternal morbidity. With a distinguished panel of Professors Eyal Sheiner, Gian Carlo Di Renzo, Shali Mazaki-Tovi and Nir Melamed, this webinar will address and share new perspectives on the prevention and monitoring of Preterm Delivery.

Date: 24 September 2020 | 1 pm (CEST) | 7 am (EDT) | 7 am (CST Asia)

Duration: Maximum 2 hours

Webinar ID: 856 8826 9334

Register for Free Here: https://sciforum.net/conference/ClinicalMed-2

Chair:

Speakers:

For any questions about the webinar, please send an email to webinars@mdpi.com.

MDPI will be attending the conference Neuroscience 2020, which will be hosted in Washington, USA, 24–28 October 2020.

SfN’s 50th annual meeting is the premier venue for the presentation of emerging science in the field of neurosciences, where one can learn from experts, forge collaborations with peers, explore new tools and technologies, and advance their career.

The following MDPI journals will be represented:

• Brain Sciences (leading journal)
• JCM
• Medicina
• Genes
• Children
• Cancers
• Behavioral Sciences
• Cells
• IJERPH
• Disease
• Biomedicines
• JPM
• Pathogens
• Healthcare
• IJMS
• Psych
• Pharmaceuticals
• Clocks&Sleep
• Jounal of Intelligence
• Pharmaceutics

If you are attending this conference, please feel free to stop by our booth (Booth #208). Our delegates look forward to meeting you in person, to answer any questions you may have. For more information about the conference, please visit:

https://www.sfn.org/meetings/neuroscience-2020

It is our pleasure to announce that five JCM Editorial Board Members have been listed as Highly Cited Researchers:

Prof. Fred Saad

Centre Hospitalier de Université de Montréal, Montreal, Canada
Interests: prostate cancer; biomarkers; novel therapeutics; castration resistant prostate cancer; GU cancers; metastases prevention

Prof. Dr. Gregory Y. H. Lip

1. Price-Evans Professor of Cardiovascular Medicine, University of Liverpool, United Kingdom
2. Distinguished Professor, Aalborg University, Denmark
Interests: atrial fibrillation; hypertension; thrombosis and anticoagulation

Prof. Dr. Laxmaiah Manchikanti

Pain Management Center of Paducah Associate Clinical, Anesthesiology and Perioperative Medicine, University of Louisville, 2831 Lone Oak Road, Paducah, KY 42003, USA
Interests: back pain; low back pain; opioids; spinal pain; chronic pain; interventional pain management

Dr. Michael R. Hamblin

Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA
Interests: photodynamic therapy (PDT); low-level light therapy (LLLT); wound healing and infectious disease; atherosclerotic vulnerable plaque; anti-tumor immunity; photochemical mechanisms

Prof. Dr. Russel J. Reiter

Department of Cellular &amp; Structural Biology, The UT Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA
Interests: melatonin; free radicals of disease processes and aging; oxygen derivatives

The 2019 Highly Cited Researchers list has been announced by Web of Science at:

https://recognition.webofsciencegroup.com/awards/highly-cited/2019/

We are delighted to announce the establishment of our Open Access agreement with Jisc Collections, which will allow UK institutions to benefit from access to article processing charge (APC) discounts and streamlined payment workflows.

All institutions participating in the agreement will also gain access to the MDPI online submission system where they can find full article metadata and pricing information for easy identification and additional transparency.

Eligible authors affiliated with the participating institutions are prompted to choose the corresponding Institutional Open Access Program (IOAP) when they submit an article via our online submission system.

About Jisc

Jisc's vision is for the UK to be the most digitally advanced education and research nation in the world. At its heart is the super-fast national research and education network, Janet, with built-in cyber security protection.  Jisc also provides technology solutions for its members (colleges, universities and research centres) and customers (public sector bodies), helps members save time and money by negotiating sector-wide deals and provides advice and practical assistance on digital technology. Jisc is funded by the UK higher and further education and research funding bodies and member institutions.

For more information, contact helen.dobson@jisc.ac.uk.

About MDPI

MDPI is a publisher of fully peer-reviewed, Open Access journals with a focus on thorough and rapid editorial processing. Its aim is to ensure that high-quality research is verified and made available to the research community as quickly as possible. MDPI stands at the forefront of the Open Access movement, having launched its first online journal Molecules in 1996. Today, MDPI is a leader in Open Access publishing with over 250 journals across all research disciplines, and all content published under a Creative Commons Attribution License (CC BY).

For any questions about this agreement, please contact the MDPI IOAP team at ioap@mdpi.com.

The updated citation metrics have been released in the Journal Citation Reports (JCR), published by Clarivate. The recent release of the JCR includes seventy-one MDPI titles. Out of these, 18 titles are newcomers, receiving a first Journal Impact Factor which is based on citation activity in 2019: Actuators, Agriculture, Biology, Biomedicines, Biosensors, Chemosensors, Children, Healthcare, Journal of Fungi, Journal of Personalized Medicine (JPM), Land, Life, Magnetochemistry, Membranes, Pharmaceuticals, Photonics, Separations and Toxics.

• Out of the previously listed journals, a total of 72 percent boast an increased Impact Factor.
• 25 journals are ranked among the top 25% of journals in at least one of the categories they are ranked for.
• Articles published in 2019 in MDPI journals account for approximately 17 percent of of articles published in gold Open Access journals covered in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI).
  
  

First Impact Factors

Updated Impact Factors